SAVE: A grading protocol for clinically significant diabetic macular oedema based on optical coherence tomography and fluorescein angiography

British Journal of Ophthalmology

Volumn 98, Issue 12, 2014, Pages 1612-1617

  Bolz, Matthias ^a   Lammer, Jan ^a   Deak, Gabor ^a   Pollreisz, Andreas ^a   Mitsch, Christoph ^a   Scholda, Christoph ^a   Kundi, Michael ^b   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medical University of Vienna and Wiener Werkstaette for Suicide Research   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADULT; ANGIOGRAPHY DEVICE; ARTICLE; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; IMAGE QUALITY; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; LASER COAGULATION; LOW LEVEL LASER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PROSPECTIVE STUDY; RETINA FLUORESCEIN ANGIOGRAPHY; SAVE GRADING SYSTEM; SUBRETINAL FLUID; VITREORETINOPATHY; BLOOD RETINA BARRIER; CLASSIFICATION; CLINICAL PROTOCOL; COMPLICATION; DIABETIC RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; MACULAR EDEMA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVER VARIATION; PATHOLOGY; VITREOUS BODY;

BLOOD-RETINAL BARRIER; CLINICAL PROTOCOLS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR EDEMA; MIDDLE AGED; OBSERVER VARIATION; PROSPECTIVE STUDIES; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; VITREOUS BODY;

EID: 84911990411     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304564     Document Type: Article

References (18)

1. Chew EY, Klein ML, Ferris FL, et al. Association of Elevated Serum Lipid Levels With Retinal Hard Exudate in Diabetic Retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 1996;114:1079-84.
2. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16.
3. Antonetti DA, Barber AJ, Khin S, et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953-9.
4. Kim NR, Kim YJ, Chin HS, et al. Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation. Br J Ophthalmol 2009;93:901-5.
5. Soliman W, Sander B, Hasler PW, et al. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography. Acta Ophthalmol (Copenh) 2008;86:34-9.
6. Wessel MM, Nair N, Aaker GD, et al. Peripheral retinal ischaemia, as evaluated by ultra-widefi eld fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol 2012;96:694-8.
7. Browning DJ, Altaweel MM, Bressler NM, et al. Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol 2008;146:649-55, 655.e1-6.
8. Bolz M, Ritter M, Schneider M, et al. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema. Ophthalmology 2009;116:66-72.
9. Sonoda S, Sakamoto T, Shirasawa M, et al. Correlation between reflectivity of subretinal fluid in OCT images and concentration of intravitreal VEGF in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 2013;54:5367-74.
10. Zhu D, Zhu H, Wang C, et al. Intraocular soluble intracellular adhesion molecule-1correlates with subretinal fluid height of diabetic macular edema. Indian J Ophthalmol 2014;62:295-8.
11. Kozak I, El-Emam SY, Cheng L, et al. Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema. Retina Published Online First: 1 April 2014.
12. Grover S, Murthy RK, Brar VS, et al. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (Spectralis). Am J Ophthalmol 2009;148:266-71.
13. Liu T, Hu AY, Kaines A, et al. A pilot study of normative data for macular thickness and volume measurements using cirrus high-de finition optical coherence tomography. Retina 2011;31:1944-50.
14. Duker JS, Kaiser PK, Binder S, et al. The International Vitreomacular Traction Study Group classi fication of vitreomacular adhesion, traction, and macular hole. Ophthalmology 2013;120:2611-19.
15. Lammer J, Scholda C, Prünte C, et al. Retinal thickness and volume measurements in diabetic macular edema: a comparison of four optical coherence tomography systems. Retina 2011;31:48-55.
16. Pelosini L, Hull CC, Boyce JF, et al. Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci 2011;52:2741-8.
17. Bolz M, Kriechbaum K, Simader C, et al. In vivo retinal morphology after grid laser treatment in diabetic macular edema. Ophthalmology 2010;117:538-44.
18. Montero JA, Ruiz-Moreno JM, Correa ME. Intravitreal anti-VEGF drugs as adjuvant therapy in diabetic retinopathy surgery. Curr Diabetes Rev 2011;7: 176-84.